Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06280664 · ClinicalTrials.gov registry record

Efficacy Of Hiatal Closure For GERD

A clinical trial of Gastro Esophageal Reflux, sponsored by University of Chicago.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06280664 is a study of Gastro Esophageal Reflux that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 40 participants, below the 12,940-participant average among 7 other Gastro Esophageal Reflux trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06280664, a study of Gastro Esophageal Reflux, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

Conditions Studied

Gastro Esophageal Reflux

Study Locations (1)

Illinois

  • The University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-10-02
Est. Completion 2028-10

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06280664

The ClinicalTrials.gov registry entry for NCT06280664 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,940-participant average among 7 other Gastro Esophageal Reflux trials with a reported enrollment target (100% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastro Esophageal Reflux appearing as the primary indexed condition, and to 0 interventions.

NCT06280664 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06280664 about?

NCT06280664 is a clinical study titled "Efficacy Of Hiatal Closure For GERD". The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

What is the current status of trial NCT06280664?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2020-10-02. Estimated completion is 2028-10.

What conditions does trial NCT06280664 study?

This clinical trial studies the following conditions: Gastro Esophageal Reflux.

Who is sponsoring clinical trial NCT06280664?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06280664 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastro Esophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gastro Esophageal Reflux

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.